Interest of a Hybrid Connected Watch for Cardiac Rhythm Monitoring in Post-operative Cardiac Surgery
NCT ID: NCT05664308
Last Updated: 2026-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
106 participants
OBSERVATIONAL
2024-03-19
2028-03-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnosis of Postoperative Atrial Fibrillation by a Smartwatch
NCT05573633
Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch
NCT06724718
Biventricular Epicardial Pacing Post Cardiac Surgery in Patients With Left Ventricular Ejection Fractions Less Than 45%
NCT00604110
Prolonged Continuous ECG Monitoring Prior to Transcatheter Aortic Valve Implantation
NCT03561805
Electrical Cardioversion As a Predictor in Postoperative Preservation of Sinus Rhythm
NCT06654401
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Electrocardiogram
Clinical follow-up (ECG)
Clinical follow-up with a consultation at the University Hospital at 3, 6, and 12 months, with an ECG at each visit.
Electrocardiogram + Connect Watch
Clinical follow-up (ECG)
Clinical follow-up with a consultation at the University Hospital at 3, 6, and 12 months, with an ECG at each visit.
Ongoing monitoring
Once operated, patients will be monitored remotely via a computerized data transfer routine anonymized by the WITHINGS software, based on the data from the watch.
It's contractually agreed with WITHINGS that the transmissions will be scheduled and transmitted weekly to the center.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clinical follow-up (ECG)
Clinical follow-up with a consultation at the University Hospital at 3, 6, and 12 months, with an ECG at each visit.
Ongoing monitoring
Once operated, patients will be monitored remotely via a computerized data transfer routine anonymized by the WITHINGS software, based on the data from the watch.
It's contractually agreed with WITHINGS that the transmissions will be scheduled and transmitted weekly to the center.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Agreeing to participate in the study and having signed an informed consent.
* Agreeing to undergo 12 months of postoperative monitoring.
Exclusion Criteria
* Patient who does not have a smartphone compatible with the connected watch.
* Patient unable to perform an ECG measurement independently.
* Patient with a physical constraint to the measurement (arteriovenous fistula...)
* Minors
* Pregnant or breast-feeding women
* Adults under guardianship, under curatorship
* Patients whose life expectancy is less than 1 year
* Patients participating in another therapeutic trial likely to impact the evaluation criteria of the MONHYCARD study
* Contraindication to long-term anticoagulants
* Patients implanted with a mechanical valve prosthesis pre-operatively or after surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Nantes
Nantes, Loire Atlantique, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC22_0604
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.